当前位置: X-MOL 学术J. Pineal. Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The Galphai and Galphaq proteins mediate the effects of melatonin on steroid/thyroid hormone receptor transcriptional activity and breast cancer cell proliferation.
Journal of Pineal Research ( IF 8.3 ) Pub Date : 2008-08-13 , DOI: 10.1111/j.1600-079x.2008.00620.x
Ling Lai 1 , Lin Yuan , Qi Chen , Chunmin Dong , Lulu Mao , Brian Rowan , Tripp Frasch , Steven M Hill
Affiliation  

Melatonin, via its MT1 receptor, but not the MT2 receptor, can modulate the transcriptional activity of various nuclear receptors - estrogen receptor alpha (ERalpha) and retinoic acid receptor alpha (RARalpha), but not ERbeta- in MCF-7, T47D, and ZR-75-1 human breast cancer cell lines. The anti-proliferative and nuclear receptor modulatory actions of melatonin are mediated via the MT1 G protein-coupled receptor expressed in human breast cancer cells. However, the specific G proteins and associated pathways involved in the nuclear receptor transcriptional regulation by melatonin are not yet clear. Upon activation, the MT1 receptor specifically couples to the G(alphai2), G(alphai3), G(alphaq), and G(alphall) proteins, and via activation of G(alphai2) proteins, melatonin suppresses forskolin-induced 3',5'-cyclic adenosine monophosphate production, while melatonin activation of G(alphaq), is able to inhibit phospholipid hydrolysis and ATP's induction of inositol triphosphate production in MCF-7 breast cancer cells. Employing dominant-negative and dominant-positive) forms of these G proteins, we demonstrate that G(alphai2) proteins mediate the suppression of estrogen-induced ERalpha transcriptional activity by melatonin, while the G(q) protein mediates the enhancement of retinoid-induced RARalpha transcriptional activity by melatonin. However, the growth-inhibitory actions of melatonin are mediated via both G(alphai2) and G(alphaq) proteins.

中文翻译:

Galphai 和 Galphaq 蛋白介导褪黑激素对类固醇/甲状腺激素受体转录活性和乳腺癌细胞增殖的影响。

褪黑激素通过其 MT1 受体,而不是 MT2 受体,可以调节各种核受体的转录活性 - 雌激素受体 α (ERalpha) 和视黄酸受体 α (RARalpha),但不能调节 MCF-7、T47D 中的 ERbeta- ZR-75-1 人乳腺癌细胞系。褪黑激素的抗增殖和核受体调节作用是通过人乳腺癌细胞中表达的 MT1 G 蛋白偶联受体介导的。然而,褪黑激素参与核受体转录调控的特定 G 蛋白和相关通路尚不清楚。激活后,MT1 受体与 G(alphai2)、G(alphai3)、G(alphaq) 和 G(alphall) 蛋白特异性偶联,并且通过 G(alphai2) 蛋白的激活,褪黑激素抑制毛喉素诱导的 3'、 5' -环磷酸腺苷的产生,同时 G(alphaq) 的褪黑激素激活,能够抑制磷脂水解和 ATP 诱导 MCF-7 乳腺癌细胞中肌醇三磷酸的产生。使用这些 G 蛋白的显性阴性和显性阳性)形式,我们证明 G(alphai2) 蛋白介导了褪黑激素对雌激素诱导的 ERalpha 转录活性的抑制,而 G(q) 蛋白介导了维甲酸诱导的增强褪黑激素的 RARalpha 转录活性。然而,褪黑激素的生长抑制作用是通过 G(alphai2) 和 G(alphaq) 蛋白介导的。使用这些 G 蛋白的显性阴性和显性阳性)形式,我们证明 G(alphai2) 蛋白介导了褪黑激素对雌激素诱导的 ERalpha 转录活性的抑制,而 G(q) 蛋白介导了维甲酸诱导的增强褪黑激素的 RARalpha 转录活性。然而,褪黑激素的生长抑制作用是通过 G(alphai2) 和 G(alphaq) 蛋白介导的。使用这些 G 蛋白的显性阴性和显性阳性)形式,我们证明 G(alphai2) 蛋白介导了褪黑激素对雌激素诱导的 ERalpha 转录活性的抑制,而 G(q) 蛋白介导了维甲酸诱导的增强褪黑激素的 RARalpha 转录活性。然而,褪黑激素的生长抑制作用是通过 G(alphai2) 和 G(alphaq) 蛋白介导的。
更新日期:2019-11-01
down
wechat
bug